Shourideh Amir, Maddah Reza, Amiri Bahareh Shateri, Basharat Zarrin, Shadpirouz Marzieh
Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, Cyprus.
Department of Bioprocess Engineering, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Iran J Public Health. 2024 Jun;53(6):1332-1342.
Liver hepatocellular carcinoma (LIHC) is a common cancer with a poor prognosis and high recurrence rate. We aimed to identify potential biomarkers for LIHC by investigating the involvement of hub genes, microRNAs (miRNAs), transcription factors (TFs), and protein kinases (PKs) in its occurrence.
we conducted a bioinformatics analysis using microarray datasets, the TCGA-LIHC dataset, and text mining to identify differentially expressed genes (DEGs) associated with LIHC. They then performed functional enrichment analysis and gene-disease association analysis. The protein-protein interaction network of the genes was established, and hub genes were identified. The expression levels and survival analysis of these hub genes were evaluated, and their association with miRNAs, TFs, and PKs was assessed.
The analysis identified 122 common genes involved in LIHC pathogenesis. Ten hub genes were filtered out, including and . The expression level of all hub genes was confirmed, and high expression levels of all hub genes were correlated with poor overall survival of LIHC patients.
Identifying potential biomarkers for LIHC can aid in the design of targeted treatments and improve the survival of LIHC patients. The findings of this study provide a basis for further research in the field of LIHC and contribute to the understanding of its molecular pathogenesis.
肝细胞肝癌(LIHC)是一种常见癌症,预后较差且复发率高。我们旨在通过研究核心基因、微小RNA(miRNA)、转录因子(TF)和蛋白激酶(PK)在其发生过程中的作用,来确定LIHC的潜在生物标志物。
我们使用微阵列数据集、TCGA-LIHC数据集和文本挖掘进行生物信息学分析,以识别与LIHC相关的差异表达基因(DEG)。然后进行功能富集分析和基因-疾病关联分析。建立基因的蛋白质-蛋白质相互作用网络,并识别核心基因。评估这些核心基因的表达水平和生存分析,并评估它们与miRNA、TF和PK的关联。
分析确定了122个参与LIHC发病机制的常见基因。筛选出10个核心基因,包括和。所有核心基因的表达水平均得到证实,所有核心基因的高表达水平与LIHC患者较差的总生存率相关。
确定LIHC的潜在生物标志物有助于设计靶向治疗并提高LIHC患者的生存率。本研究结果为LIHC领域的进一步研究提供了基础,并有助于理解其分子发病机制。